The results of a series of experiments in cell biology and molecular biology indicate that KLF6 can be a new early biomarker to diagnose AKI and participate in the mechanism of renal IR by regulating the expression of inflammatory cytokines. This evidence concerns the gene KLF6 and acute kidney injury.